FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to production of recombinant proteins enhancing immunogenicity of an immunogenic polypeptide sequence, that can be used in medicine. Protein comprising a sequence of an immunogenic polypeptide and a sequence expressing the neutralizing domain of the growth factor is produced recombinantly, wherein said growth factor is a human own protein and is separated from said immunogenic polypeptide sequence by a peptide GS spacer.
EFFECT: invention allows to significantly increase immunogenicity of various sequences of immunogenic polypeptides.
7 cl, 44 dwg, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PROTEINS AND THEIR APPLICATIONS IN THERAPEUTIC PURPOSES | 2018 |
|
RU2766595C2 |
| SELF-ASSEMBLY SYNTHETIC PROTEINS | 2014 |
|
RU2801230C2 |
| SELF-ASSEMBLING SYNTHETIC PROTEINS | 2014 |
|
RU2747857C2 |
| THERAPEUTIC COMPOSITION FOR REDUCING RESISTANCE TO TYROSINE KINASE INHIBITORS | 2016 |
|
RU2735493C2 |
| COMBINATIONS OF GROWTH-REGULATING FACTORS AND HORMONES FOR NEOPLASIA TREATMENT | 2003 |
|
RU2321422C2 |
| RECEPTOR ANTAGONISTS FOR TREATING METASTATIC CANCER | 2009 |
|
RU2455026C2 |
| BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY | 2005 |
|
RU2433831C2 |
| PDGFRα ANTIBODIES FOR TREATING SECONDARY BONE TUMOUR | 2006 |
|
RU2502523C2 |
| METHODS OF PREDICTING RESPONSE OF TRIPLE NEGATIVE MAMMARY GLAND CANCER TO THERAPY | 2011 |
|
RU2558931C2 |
| HUMAN ANTIBODIES TO RECEPTOR OF EPIDERMAL GROWTH FACTOR | 2005 |
|
RU2402569C2 |
